A SBIR Phase II contract was awarded to Humacyte in August, 2013 for $2,947,501.0 USD from the U.S. Department of Health & Human Services.
A SBIR Phase I contract was awarded to Humacyte for $236,549.0 USD from the U.S. Department of Health & Human Services.
A SBIR Phase I contract was awarded to Humacyte for $217,277.0 USD from the U.S. Department of Health & Human Services.
A SBIR Phase II contract was awarded to Humacyte for $2,947,501.0 USD from the U.S. Department of Health & Human Services.
A SBIR Phase II contract was awarded to Humacyte for $1,189,820.0 USD from the U.S. Department of Health & Human Services.